Köppl, Christoph
Buchinger, Wolfgang
Striedner, Gerald
Cserjan-Puschmann, Monika
Funding for this research was provided by:
The COMET center: acib: Next Generation Bioproduction is funded by BMK, BMDW, SFG, Standortagentur Tirol, Government of Lower Austria, and Vienna Business Agency
Article History
Received: 30 November 2023
Accepted: 27 February 2024
First Online: 20 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: Boehringer Ingelheim RCV GmbH & Co KG filed a patent covering the use and application of the <i>T7AC</i><sub><i>rare</i></sub> constructs developed in this study.